Sunset Capital Assets, Inc. (SNST)

[Roland Rick Perry]

Thanks, Bounty Man!

Good to see you're studying this. The Aphex story isn't a "next six-months or next-year" story. This is a "where will they be in 5 years story," And the potential is mind-boggling.

We've studied Purell in-depth, a simple alcohol solution that is near impossible (except for brand awareness) to distinguish from nearly every other alcohol-based sanitizer you see, on the counter of your corner 7-11 or gas station.

But what Purell has done over the last ten years is mind-boggling.

Meet The Billion-Dollar Family Company That Makes Purell
http://internetstockreview.com/meet-the-billion-dollar-family-company-that-makes-purell-forbes/

So you can imagine if consumers (on a widespread basis) someday come to believe, that this is a superior and more effective solution than mere alcohol...all bets on.

Of course, usurping an industry giant is never easy, but the target has been identified.

Secondly, as you can see from the various patent filings you posted, the market for Aphex is much bigger than just hand sanitizing, as the vegetable cleansing filing illustrates.

Have you ever tried using any disinfectant (scrubbing bubbles lol) on your vegetables which could be contaminated with E-Coli? Of course not, you'd poison yourself. Ditto with kitchen counters.

Raw vegetables and fruits are often a source for E. coli because the bacteria can't be fully washed off. Fact.

https://www.upi.com/Top_News/US/2019/11/19/FDA-begins-testing-romaine-lettuce-after-E-coli-outbreaks-sicken-hundreds/1711574113189/

So for fun -- look at the patent filings and make of list of all possible uses you can come up with this weekend for Hy-IQ.

Note, we are not commenting on SNST as the merger has not been finalized. Aphex is additionally a client of Institutional Analyst which is compensated to provide ongoing progress reporting. Reports can be found on the Internet | Biotech Stock Review website which launched in 1998. Disclosure and disclaimer details can be found on each report we author and distribute.

We know a thing or two because we've seen a thing or two.